author-photo

Silvia Paola Corona

University of Trieste

15

Papers

51

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Erratum to 'Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis' [Eur J Cancer 149 (2021) 134-152].

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (11)
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature

2021 Pharmaceuticals, policy and law
Show All
- Source
- Cite
- Save
Citations (0)
Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancers

2020 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (2)
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study.

2020 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (2)
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study.

2020 Oncotarget
Show All
- Source
- Cite
- Save
Citations (2)
ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment.

2020 Tumor Biology
Show All
- Source
- Cite
- Save
Citations (2)
Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis

2020 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (2)
Immune-gene signature: a new tool for patient selection for checkpoint inhibitors?

2020 Future Oncology
Show All
- Source
- Cite
- Save
Citations (1)